LENSAR, Inc. Common Stock (LNSR) is a publicly traded Healthcare sector company. As of November 3, 2026, LNSR trades at $5.66 with a market cap of $71.75M and a P/E ratio of 5.03. LNSR moved +0.00% today. Year to date, LNSR is -51.15%; over the trailing twelve months it is -53.89%. Its 52-week range spans $4.95 to $17.31. Analyst consensus is strong buy with an average price target of $11.33. Rallies surfaces LNSR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest LNSR news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $5.66 |
| Market Cap | $71.75M |
| P/E Ratio | 5.03 |
| EPS | $1.27 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.31 |
| 52-Week Low | $4.95 |
| Volume | 1.60K |
| Avg Volume | 0 |
| Revenue (TTM) | $60.26M |
| Net Income | $34.70M |
| Gross Margin | 48.34% |
3 analysts cover LNSR: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $11.33.